Syn-AKE is a research peptide modeled after Waglerin-1, a peptide found in the venom of the temple viper, designed as a tripeptide analog that targets subunits of the nicotinic acetylcholine receptor (nAChR) in experimental systems. Preclinical studies show that Syn-AKE modulates neuromuscular signal transduction and the activity of ion channel receptors and provides a model for the study of peptide–receptor interactions and synaptic transmission. It is used in biochemical and dermatological research that investigates peptide-based receptor modulation and neurochemical signaling pathways.